Literature DB >> 31361899

Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Maria Tejada1, Carol Viele1, Kord M Kober1, Bruce A Cooper1, Steven M Paul1, Laura B Dunn2, Marilyn J Hammer3, Fay Wright4, Yvette P Conley5, Jon D Levine6, Christine Miaskowski1.   

Abstract

STUDY
OBJECTIVES: Purposes of this study were to identify subgroups of patients with distinct sleep disturbance profiles and to evaluate for differences in demographic, clinical, and various sleep characteristics, as well for differences in the severity of co-occurring symptoms among these subgroups.
METHODS: Outpatients with breast, gynecological, gastrointestinal, or lung cancer (n = 1331) completed questionnaires six times over two chemotherapy cycles. Self-reported sleep disturbance was evaluated using the General Sleep Disturbance Scale (GSDS). Latent profile analysis was used to identify distinct subgroups.
RESULTS: Three latent classes with distinct sleep disturbance profiles were identified (Low [25.5%], High [50.8%], Very High [24.0%]) across the six assessments. Approximately 75% of the patients had a mean total GSDS score that was above the clinically meaningful cutoff score of at least 43 across all six assessments. Compared to the Low class, patients in High and Very High classes were significantly younger, had a lower functional status, had higher levels of comorbidity, and were more likely to be female, more likely to have childcare responsibilities, less likely to be employed, and less likely to have gastrointestinal cancer. For all of the GSDS subscale and total scores, significant differences among the latent classes followed the expected pattern (Low < High < Very High). For trait and state anxiety, depressive symptoms, morning and evening fatigue, decrements in attentional function, and decrements in morning and evening energy, significant differences among the latent classes followed the expected pattern (Low < High < Very High).
CONCLUSIONS: Clinicians need to perform in-depth assessments of sleep disturbance and co-occurring symptoms to identify high-risk patients and recommend appropriate interventions. © Sleep Research Society 2019. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anxiety; attentional function; cancer; chemotherapy; depression; fatigue; latent profile analysis; pain; sleep disturbance

Mesh:

Substances:

Year:  2019        PMID: 31361899      PMCID: PMC6783885          DOI: 10.1093/sleep/zsz151

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  74 in total

1.  Self-reported sleep disturbances in employed women.

Authors:  K A Lee
Journal:  Sleep       Date:  1992-12       Impact factor: 5.849

2.  Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.

Authors:  E Cash; S E Sephton; A B Chagpar; D Spiegel; W N Rebholz; L A Zimmaro; J M Tillie; F S Dhabhar
Journal:  Brain Behav Immun       Date:  2015-02-26       Impact factor: 7.217

Review 3.  Physical activity and obesity prevention: a review of the current evidence.

Authors:  Nicholas J Wareham; Esther M F van Sluijs; Ulf Ekelund
Journal:  Proc Nutr Soc       Date:  2005-05       Impact factor: 6.297

Review 4.  Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations.

Authors:  Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden
Journal:  J Natl Cancer Inst       Date:  2017-01-24       Impact factor: 13.506

Review 5.  Future Directions in Symptom Cluster Research.

Authors:  Christine Miaskowski
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

Review 6.  Insomnia in the context of cancer: a review of a neglected problem.

Authors:  J Savard; C M Morin
Journal:  J Clin Oncol       Date:  2001-02-01       Impact factor: 44.544

7.  Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance.

Authors:  Christina Van Onselen; Bruce A Cooper; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Steven Paul; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2012-10       Impact factor: 3.603

8.  Depression and vasomotor symptoms in young breast cancer survivors: the mediating role of sleep disturbance.

Authors:  Eynav E Accortt; Julienne E Bower; Annette L Stanton; Patricia A Ganz
Journal:  Arch Womens Ment Health       Date:  2015-01-18       Impact factor: 3.633

9.  The effect of symptom clusters on functional status and quality of life in women with breast cancer.

Authors:  Marylin J Dodd; Maria H Cho; Bruce A Cooper; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2009-11-07       Impact factor: 2.398

10.  Sleep disturbance in cancer patients.

Authors:  Judith R Davidson; Alistair W MacLean; Michael D Brundage; Karleen Schulze
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

View more
  6 in total

1.  Neuropsychological Symptoms and Intrusive Thoughts Are Associated With Worse Trajectories of Chemotherapy-Induced Nausea.

Authors:  Komal Singh; Steven M Paul; Kord M Kober; Yvette P Conley; Fay Wright; Jon D Levine; Paule V Joseph; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-11-02       Impact factor: 3.612

2.  Prevalence of Sleep Disturbance in Patients With Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mohammed Al Maqbali; Mohammed Al Sinani; Ahmad Alsayed; Alexander M Gleason
Journal:  Clin Nurs Res       Date:  2022-04-28       Impact factor: 1.724

3.  Distinct Worst Pain Profiles in Oncology Outpatients Undergoing Chemotherapy.

Authors:  Joosun Shin; Kate Oppegaard; Alejandra Calvo-Schimmel; Carolyn Harris; Bruce A Cooper; Steven M Paul; Yvette P Conley; Marilyn J Hammer; Frances Cartwright; Kord M Kober; Jon D Levine; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2022-04-12       Impact factor: 2.760

4.  Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.

Authors:  Yufen Lin; Donald E Bailey; Sharron L Docherty; Laura S Porter; Bruce A Cooper; Steven M Paul; Marilyn J Hammer; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

5.  Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer.

Authors:  Susan Grayson; Susan Sereika; Caroline Harpel; Emilia Diego; Jennifer G Steiman; Priscilla F McAuliffe; Susan Wesmiller
Journal:  Support Care Cancer       Date:  2021-07-10       Impact factor: 3.603

6.  Effects of a Clinic-Based Exercise Program on Sleep Disturbance Among Cancer Survivors.

Authors:  Mary C Hidde; Heather J Leach; Ryan J Marker; John C Peters; W Thomas Purcell
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.